| Dr Christopher Patrick Myers, MD, PHD | |
|
2002 Medical Pkwy Ste 235, Annapolis, MD 21401-3260 | |
| (410) 266-2770 | |
| (410) 841-6251 |
| Full Name | Dr Christopher Patrick Myers |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 18 Years |
| Location | 2002 Medical Pkwy Ste 235, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578768024 | NPI | - | NPPES |
| 1069 | Other | MD | ARA - BCBS |
| 10690036 | Other | MD | BLUE CHOICE |
| 38110091 | Other | MD | SHIPLEYS IMAGING |
| CA1932 P01063488 | Other | MD | AAD RAILROAD PTAN |
| KC46SH 60340002 | Other | MD | SHIPLEYS IMAGING CAREFIRST |
| 044204600 | Other | MD | MEDICAL ASSISTANCE - SHIPLEYS |
| S645 60056008 | Other | MD | AAD CAREFIRST |
| 044204600 | Other | MD | ARA MEDICAID |
| 044204600 | Medicaid | MD | |
| 219037DZYC | Other | MD | MEDICARE PIN - BCF GROUP |
| 219037ZCKL | Other | MD | SHIPLEYS GROUP PTAN |
| 219037ZEDL | Other | MD | AAD |
| K606AN | Other | MD | ARA - BCBS |
| 10730030 | Other | MD | AAD PROVIDER |
| 219037ZD7B | Other | MD | AAD GROUP PTAN |
| CK4885 P01055819 | Other | MD | BOWIE RAILROAD PTAN |
| 9052710 | Other | MD | AETNA AAD SHIPLEYS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | D66722 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Doctors' Community Hospital | Lanham, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Luminis Health Imaging, Inc. | 8729054598 | 25 |
| Brown, Croft, Frazier, Pa | 9537101746 | 24 |
| Luminis Health Imaging, Inc. | 8729054598 | 25 |
| Brown, Croft, Frazier, Pa | 9537101746 | 24 |
News Archive
Smoothie King, the 1973 originator of the nutritional fruit smoothie, has reached an agreement with BW Ventures, LTD, to develop multiple stores in the Cayman Islands within the next few years.
"World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable 'lifestyle' diseases," including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), "amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries," the Guardian reports.
Mark Wagar, President and CEO of Empire BlueCross BlueShield urged further improvement to the federal health care reform legislation that today does little to control the rising costs of health care and will increase premiums for too many New Yorkers and too many across the nation.
Studying the most common type of lung cancer, researchers have uncovered mutations in a cell-signaling pathway that plays a role in forming tumors.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
› Verified 1 days ago
| Entity Name | Luminis Health Imaging, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366420879 PECOS PAC ID: 8729054598 Enrollment ID: O20040903000184 |
News Archive
Smoothie King, the 1973 originator of the nutritional fruit smoothie, has reached an agreement with BW Ventures, LTD, to develop multiple stores in the Cayman Islands within the next few years.
"World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable 'lifestyle' diseases," including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), "amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries," the Guardian reports.
Mark Wagar, President and CEO of Empire BlueCross BlueShield urged further improvement to the federal health care reform legislation that today does little to control the rising costs of health care and will increase premiums for too many New Yorkers and too many across the nation.
Studying the most common type of lung cancer, researchers have uncovered mutations in a cell-signaling pathway that plays a role in forming tumors.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
› Verified 1 days ago
| Entity Name | Anne Arundel Urology, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164426045 PECOS PAC ID: 9032178918 Enrollment ID: O20041006000993 |
News Archive
Smoothie King, the 1973 originator of the nutritional fruit smoothie, has reached an agreement with BW Ventures, LTD, to develop multiple stores in the Cayman Islands within the next few years.
"World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable 'lifestyle' diseases," including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), "amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries," the Guardian reports.
Mark Wagar, President and CEO of Empire BlueCross BlueShield urged further improvement to the federal health care reform legislation that today does little to control the rising costs of health care and will increase premiums for too many New Yorkers and too many across the nation.
Studying the most common type of lung cancer, researchers have uncovered mutations in a cell-signaling pathway that plays a role in forming tumors.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
› Verified 1 days ago
| Entity Name | Brown, Croft, Frazier, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902807324 PECOS PAC ID: 9537101746 Enrollment ID: O20050527000410 |
News Archive
Smoothie King, the 1973 originator of the nutritional fruit smoothie, has reached an agreement with BW Ventures, LTD, to develop multiple stores in the Cayman Islands within the next few years.
"World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable 'lifestyle' diseases," including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), "amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries," the Guardian reports.
Mark Wagar, President and CEO of Empire BlueCross BlueShield urged further improvement to the federal health care reform legislation that today does little to control the rising costs of health care and will increase premiums for too many New Yorkers and too many across the nation.
Studying the most common type of lung cancer, researchers have uncovered mutations in a cell-signaling pathway that plays a role in forming tumors.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Patrick Myers, MD, PHD 2002 Medical Pkwy Ste 235, Annapolis, MD 21401-3260 Ph: (410) 266-2770 | Dr Christopher Patrick Myers, MD, PHD 2002 Medical Pkwy Ste 235, Annapolis, MD 21401-3260 Ph: (410) 266-2770 |
News Archive
Smoothie King, the 1973 originator of the nutritional fruit smoothie, has reached an agreement with BW Ventures, LTD, to develop multiple stores in the Cayman Islands within the next few years.
"World leaders at a meeting of the United Nations on Monday will agree to a deal to try to curb the spread of preventable 'lifestyle' diseases," including heart disease, cancers and diabetes, also known as non-communicable diseases (NCDs), "amid concern that progress is already being hampered by powerful lobbyists from the food, alcohol and tobacco industries," the Guardian reports.
Mark Wagar, President and CEO of Empire BlueCross BlueShield urged further improvement to the federal health care reform legislation that today does little to control the rising costs of health care and will increase premiums for too many New Yorkers and too many across the nation.
Studying the most common type of lung cancer, researchers have uncovered mutations in a cell-signaling pathway that plays a role in forming tumors.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
› Verified 1 days ago
Luqman K Dad, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite 235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Quang Nguyen, Radiology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Mark S Radowich, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite 235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Thomas B. Lank, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 122 Defense Hwy, Chesapeake Medical Imaging, Annapolis, MD 21401 Phone: 410-571-0350 Fax: 410-571-9348 | |
Dr. Frank J Groshek, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy Ste 235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Mark Cameron Davis, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 845 Coachway, Annapolis, MD 21401 Phone: 952-595-1100 Fax: 612-294-4903 | |
Dr. Kerry J. Thompson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite #235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 |